OVID
Ovid Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$422.74M
P/E Ratio
—
EPS
$-0.21
Beta
0.18
52W High
$3.10
52W Low
$0.28
50-Day MA
$2.62
200-Day MA
$1.85
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.79
PEG Ratio
0.00
About Ovid Therapeutics Inc
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $7.12M |
| Gross Profit (TTM) | $7.12M |
| EBITDA | $-48.17M |
| Operating Margin | -679.00% |
| Return on Equity | -18.80% |
| Return on Assets | -19.70% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $1.19 |
| Price-to-Book | 2.08 |
| Price-to-Sales (TTM) | 59.36 |
| EV/Revenue | 37.91 |
| EV/EBITDA | -0.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 845.00% |
| Shares Outstanding | $186.64M |
| Float | $152.44M |
| % Insiders | 6.99% |
| % Institutions | 61.56% |
Historical Volatility
HV 10-Day
64.48%
HV 20-Day
65.15%
HV 30-Day
58.33%
HV 60-Day
72.08%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($5.47 target)
10
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026